Insider trading

Period: 12 months Minimum amount: $1M × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

7,152 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

7,152 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

7,152 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

7,152 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
7,152 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
7,152 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

7,152 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
17 Feb 2026
Brown Grant SVP & Chief Financial Officer
Sold on a plan
$1.71M 20,608 at 83.06
31.7%
Planned (10b5-1)
17 Feb 2026
Wupen Yuen PRESIDENT, GLOBAL BUS. UNITS
Sold on a plan
$1.70M 3,157 at 538.00
3.4%
Planned (10b5-1)
17 Feb 2026
Zeidel Darren General Counsel
Sold on a plan
$1.64M 5,040 at 325.79
19.9%
Planned (10b5-1)
17 Feb 2026
Sijbrandij Sytse Director · indirect
Sold on a plan 2×
$1.54M 54,300 at 28.41
100%
Sold half or more
17 Feb 2026
Lane Nick See Remarks
Sold on a plan 4×
$1.35M 30,000 at 44.99
21.8%
Planned (10b5-1)
17 Feb 2026
Southern William Bradley Chief Executive Officer
Sold on a plan 4×
$1.26M 14,166 at 89.29
3.0%
Planned (10b5-1)
17 Feb 2026
Biller Jonathan EVP and Chief Legal Officer
Sold on a plan
$1.21M 2,476 at 489.46
12.7%
Planned (10b5-1)
17 Feb 2026
Lake Marianne CEO CCB · indirect
Sold on a plan
$1.20M 3,907 at 306.41
2.8%
Planned (10b5-1)
17 Feb 2026
Bunnage Mark E. EVP, Chief Scientific Officer
Sold on a plan
$1.19M 2,437 at 489.46
20.1%
Planned (10b5-1)
17 Feb 2026
Trigg William Shane Chief Executive Officer
Sold on a plan 11×
$1.18M 6,963 at 169.73
11.6%
Planned (10b5-1)
17 Feb 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Sold on a plan
$1.18M 45,000 at 26.17
64.3%
Sold half or more
17 Feb 2026
Mansueto Joseph D Executive Chairman
Sold on a plan 5×
$1.17M 7,304 at 160.63
0.1%
Planned (10b5-1)
17 Feb 2026
Petno Douglas B Co-CEO CIB
Sold on a plan
$1.07M 3,487 at 306.40
0.9%
Planned (10b5-1)
17 Feb 2026
Friedman Stacey General Counsel · indirect
Sold on a plan
$1.04M 3,404 at 306.40
5.2%
Planned (10b5-1)
17 Feb 2026
Zimpfer Matthew J. General Counsel
Sold on a plan
$1.02M 23,570 at 43.17
7.1%
Planned (10b5-1)
17 Feb 2026
Trimarchi Thomas President and CFO
Sold on a plan 2×
$1.02M 13,600 at 74.72
3.9%
Planned (10b5-1)
15 Feb 2026
Francis Richard D President and CEO
Sold on a plan 2×
$15.32M 447,778 at 34.22
62.2%
Sold half or more
15 Feb 2026
Olivan Javier Chief Operating Officer
Sold on a plan
$1.57M 2,461 at 639.77
16.9%
Planned (10b5-1)
13 Feb 2026
Kempczinski Christopher J Chairman and CEO
Sold on a plan
$8.76M 26,276 at 333.54
53.4%
Sold half or more
13 Feb 2026
Reynal Vicente See Remarks
Sold on a plan
$5.61M 55,870 at 100.39
19.6%
Planned (10b5-1)
13 Feb 2026
Doherty Catherine T. EVP, Regional Businesses
Sold on a plan 5×
$5.39M 26,165 at 206.15
27.8%
Planned (10b5-1)
13 Feb 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$5.30M 200,000 at 26.49
10.8%
Planned (10b5-1)
13 Feb 2026
Kroeger Shadrak W Pres., Industrial Solutions
Sold on a plan 11×
$3.73M 15,965 at 233.75
38.1%
Planned (10b5-1)
13 Feb 2026
Bergman Artur Chief Technology Officer · indirect
Sold on a plan 2×
$3.70M 200,847 at 18.42
8.0%
Planned (10b5-1)
13 Feb 2026
Sold on a plan 4×
$3.55M 10,000 at 355.18
1.0%
Planned (10b5-1)
13 Feb 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$3.13M 632,874 at 4.94
35.3%
Planned (10b5-1)
13 Feb 2026
Robinson Jill L. EVP, CFO & Treasurer
Sold on a plan
$2.52M 60,000 at 42.00
43.0%
Planned (10b5-1)
13 Feb 2026
Huffman Steve Ladd CEO & President · indirect
Sold on a plan 6×
$2.50M 18,000 at 138.81
3.9%
Planned (10b5-1)
13 Feb 2026
Landman Yoav CHIEF TECHNOLOGY OFFICER
Sold on a plan
$1.68M 30,000 at 55.86
0.5%
Planned (10b5-1)
13 Feb 2026
Robbins Charles Chair and CEO
Sold on a plan 4×
$1.49M 19,545 at 76.00
2.8%
Planned (10b5-1)
13 Feb 2026
Bought on a plan 3×
$1.40M 20,000 at 69.88
0.0%
Bought on a plan
13 Feb 2026
Swayze Eric EVP Research
Sold on a plan 2×
$1.28M 15,642 at 81.76
32.8%
Planned (10b5-1)
13 Feb 2026
Bohley G Frederick Allison COO,Pres.&BU Leader AT
Sold on a plan 3×
$1.20M 10,348 at 116.40
9.5%
Planned (10b5-1)
13 Feb 2026
Mansueto Joseph D Executive Chairman
Sold on a plan 6×
$1.13M 7,250 at 156.21
0.1%
Planned (10b5-1)
12 Feb 2026
Sold on a plan 12×
$38.67M 33,000 at 1,171.83
3.6%
Planned (10b5-1)
12 Feb 2026
Retort Vincent SEE REMARKS
Sold on a plan 23×
$26.62M 45,026 at 591.32
30.5%
Planned (10b5-1)
12 Feb 2026
Bergman Artur Chief Technology Officer
Sold on a plan 5×
$9.97M 619,335 at 16.09
24.4%
Planned (10b5-1)
12 Feb 2026
Kempczinski Christopher J Chairman and CEO
Sold on a plan
$8.71M 26,277 at 331.35
53.4%
Sold half or more
12 Feb 2026
Sanghi Steve President, CEO and Chair of Bd · indirect
Sold on a plan
$7.82M 94,869 at 82.46
1.0%
Planned (10b5-1)
12 Feb 2026
Perez Daniel Antonio CEO & Co-Founder
Sold on a plan
$6.71M 166,665 at 40.26
100%
Sold half or more
12 Feb 2026
Thad Trent Exec VP & CFO
Sold on a plan 4×
$4.27M 60,000 at 71.22
15.0%
Planned (10b5-1)
12 Feb 2026
Simmons Donald E. Group President, Americas
Sold on a plan
$3.64M 7,663 at 475.00
66.7%
Sold half or more
12 Feb 2026
Simon Frederic Director
Sold on a plan 3×
$3.59M 67,500 at 53.20
1.8%
Planned (10b5-1)
12 Feb 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$2.99M 632,874 at 4.73
26.1%
Planned (10b5-1)
12 Feb 2026
MERRIMAN DWIGHT A Director · indirect
Sold on a plan 4×
$2.19M 6,000 at 365.45
1.2%
Planned (10b5-1)
12 Feb 2026
Geveden Rex D President and CEO
Sold on a plan 6×
$2.03M 10,000 at 203.26
5.3%
Planned (10b5-1)
12 Feb 2026
TAYLOR KEITH D Chief Financial Officer
Sold on a plan
$1.91M 2,000 at 956.44
7.6%
Planned (10b5-1)
12 Feb 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$1.60M 65,153 at 24.49
46.1%
Planned (10b5-1)
12 Feb 2026
Flatley Edith Morgan EVP - Global CMO
Sold on a plan
$1.55M 4,692 at 331.00
43.1%
Planned (10b5-1)
12 Feb 2026
Bought on a plan 2×
$1.44M 20,000 at 71.99
0.0%
Bought on a plan
Showing 5,051–5,100 of 7,152. ← Newer Page 102 of 144 Older →